The electrocardiogram (ECG) is a vital tool for diagnosing heart diseases. However, many disease patterns are derived from outdated datasets and traditional stepwise algorithms with limited accuracy. This study presents a method for direct cardiovascular disease (CVD) diagnosis from ECG images, eliminating the need for digitization. The proposed approach utilizes a two-step curriculum learning framework, beginning with the pre-training of a classification model on segmentation masks, followed by fine-tuning on grayscale, inverted ECG images. Robustness is further enhanced through an ensemble of three models with averaged outputs, achieving an AUC of 0.9534 and an F1 score of 0.7801 on the BHF ECG Challenge dataset, outperforming individual models. By effectively handling real-world artifacts and simplifying the diagnostic process, this method offers a reliable solution for automated CVD diagnosis, particularly in resource-limited settings where printed or scanned ECG images are commonly used. Such an automated procedure enables rapid and accurate diagnosis, which is critical for timely intervention in CVD cases that often demand urgent care.

Accurate prediction of cardiovascular disease (CVD) risk is crucial for healthcare institutions. This study addresses the growing prevalence of diabetes and its strong link to heart disease by proposing an efficient CVD risk prediction model for diabetic patients using machine learning (ML) and hybrid deep learning (DL) approaches. The BRFSS dataset was preprocessed by removing duplicates, handling missing values, identifying categorical and numerical features, and applying Principal Component Analysis (PCA) for feature extraction. Several ML models, including Decision Trees (DT), Random Forest (RF), k-Nearest Neighbors (KNN), Support Vector Machine (SVM), AdaBoost, and XGBoost, were implemented, with XGBoost achieving the highest accuracy of 0.9050. Various DL models, such as Artificial Neural Networks (ANN), Deep Neural Networks (DNN), Recurrent Neural Networks (RNN), Convolutional Neural Networks (CNN), Long Short-Term Memory (LSTM), Bidirectional LSTM (BiLSTM), and Gated Recurrent Unit (GRU), as well as hybrid models combining CNN with LSTM, BiLSTM, and GRU, were also explored. Some of these models achieved perfect recall (1.00), with the LSTM model achieving the highest accuracy of 0.9050. Our research highlights the effectiveness of ML and DL models in predicting CVD risk among diabetic patients, automating and enhancing clinical decision-making. High accuracy and F1 scores demonstrate these models' potential to improve personalized risk management and preventive strategies.

Cardiovascular diseases are becoming increasingly prevalent in modern society, with a profound impact on global health and well-being. These Cardiovascular disorders are complex and multifactorial, influenced by genetic predispositions, lifestyle choices, and diverse socioeconomic and clinical factors. Information about these interrelated factors is dispersed across multiple types of textual data, including patient narratives, medical records, and scientific literature. Natural language processing (NLP) has emerged as a powerful approach for analysing such unstructured data, enabling healthcare professionals and researchers to gain deeper insights that may transform the diagnosis, treatment, and prevention of cardiac disorders. This review provides a comprehensive overview of NLP research in cardiology from 2014 to 2025. We systematically searched six literature databases for studies describing NLP applications across a range of cardiovascular diseases. After a rigorous screening process, we identified 265 relevant articles. Each study was analysed across multiple dimensions, including NLP paradigms, cardiology-related tasks, disease types, and data sources. Our findings reveal substantial diversity within these dimensions, reflecting the breadth and evolution of NLP research in cardiology. A temporal analysis further highlights methodological trends, showing a progression from rule-based systems to large language models. Finally, we discuss key challenges and future directions, such as developing interpretable LLMs and integrating multimodal data. To the best of our knowledge, this review represents the most comprehensive synthesis of NLP research in cardiology to date.

Cardiovascular disease and chronic kidney disease are major complications of diabetes, leading to high morbidity and mortality. Early detection of these conditions is critical, yet traditional diagnostic markers often lack sensitivity in the initial stages. This study integrates conventional statistical methods with machine learning approaches to improve early diagnosis of CKD and CVD in diabetic patients. Descriptive and inferential statistics were computed in SPSS to explore associations between diseases and clinical or demographic factors. Patients were categorized into four groups: Group A both CKD and CVD, Group B CKD only, Group C CVD only, and Group D no disease. Statistical analysis revealed significant correlations: Serum Creatinine and Hypertension with CKD, and Cholesterol, Triglycerides, Myocardial Infarction, Stroke, and Hypertension with CVD. These results guided the selection of predictive features for machine learning models. Logistic Regression, Support Vector Machine, and Random Forest algorithms were implemented, with Random Forest showing the highest accuracy, particularly for CKD prediction. Ensemble models outperformed single classifiers in identifying high-risk diabetic patients. SPSS results further validated the significance of the key parameters integrated into the models. While challenges such as interpretability and class imbalance remain, this hybrid statistical machine learning framework offers a promising advancement toward early detection and risk stratification of diabetic complications compared to conventional diagnostic approaches.

Cardiovascular disease (CVD) is a major pediatric health burden, and early screening is of critical importance. Electrocardiography (ECG), as a noninvasive and accessible tool, is well suited for this purpose. This paper presents the first benchmark study of deep learning for multi-label pediatric CVD classification on the recently released ZZU-pECG dataset, comprising 3716 recordings with 19 CVD categories. We systematically evaluate four representative paradigms--ResNet-1D, BiLSTM, Transformer, and Mamba 2--under both 9-lead and 12-lead configurations. All models achieved strong results, with Hamming Loss as low as 0.0069 and F1-scores above 85% in most settings. ResNet-1D reached a macro-F1 of 94.67% on the 12-lead subset, while BiLSTM and Transformer also showed competitive performance. Per-class analysis indicated challenges for rare conditions such as hypertrophic cardiomyopathy in the 9-lead subset, reflecting the effect of limited positive samples. This benchmark establishes reusable baselines and highlights complementary strengths across paradigms. It further points to the need for larger-scale, multi-center validation, age-stratified analysis, and broader disease coverage to support real-world pediatric ECG applications.

Competing risks are crucial considerations in survival modelling, particularly in healthcare domains where patients may experience multiple distinct event types. We propose CRISP-NAM (Competing Risks Interpretable Survival Prediction with Neural Additive Models), an interpretable neural additive model for competing risks survival analysis which extends the neural additive architecture to model cause-specific hazards while preserving feature-level interpretability. Each feature contributes independently to risk estimation through dedicated neural networks, allowing for visualization of complex non-linear relationships between covariates and each competing risk. We demonstrate competitive performance on multiple datasets compared to existing approaches.

Recent progress in developing general purpose text embedders has been driven by training on ever-growing corpora of synthetic LLM-generated data. Nonetheless, no publicly available synthetic dataset exists, posing a barrier to studying its role for generalization. To address this issue, we first reproduce and publicly release the synthetic data proposed by Wang et al. (Mistral-E5). Our synthetic data is high quality and leads to consistent improvements in performance. Next, we critically examine where exactly synthetic data improves model generalization. Our analysis reveals that benefits from synthetic data are sparse and highly localized to individual datasets. Moreover, we observe trade-offs between the performance on different categories and data that benefits one task, degrades performance on another. Our findings highlight the limitations of current synthetic data approaches for building general-purpose embedders and challenge the notion that training on synthetic data leads to more robust embedding models across tasks.

Accurate time-to-event prediction is integral to decision-making, informing medical guidelines, hiring decisions, and resource allocation. Survival analysis, the quantitative framework used to model time-to-event data, accounts for patients who do not experience the event of interest during the study period, known as censored patients. However, many patients experience events that prevent the observation of the outcome of interest. These competing risks are often treated as censoring, a practice frequently overlooked due to a limited understanding of its consequences. Our work theoretically demonstrates why treating competing risks as censoring introduces substantial bias in survival estimates, leading to systematic overestimation of risk and, critically, amplifying disparities. First, we formalize the problem of misclassifying competing risks as censoring and quantify the resulting error in survival estimates. Specifically, we develop a framework to estimate this error and demonstrate the associated implications for predictive performance and algorithmic fairness. Furthermore, we examine how differing risk profiles across demographic groups lead to group-specific errors, potentially exacerbating existing disparities. Our findings, supported by an empirical analysis of cardiovascular management, demonstrate that ignoring competing risks disproportionately impacts the individuals most at risk of these events, potentially accentuating inequity. By quantifying the error and highlighting the fairness implications of the common practice of considering competing risks as censoring, our work provides a critical insight into the development of survival models: practitioners must account for competing risks to improve accuracy, reduce disparities in risk assessment, and better inform downstream decisions.

-- Cardiovascular diseases (CVDs) are a main cause of mortality globally, accounting for 31% of all deaths. This study involves a cardiovascular disease (CVD) dataset comprising 68,119 records to explore the influence of numerical (age, height, weight, blood pressure, BMI) and categorical gender, cholesterol, glucose, smoking, alcohol, activity) factors on CVD occurrence. We have performed statistical analyses, including t - tests, Chi - square tests, and ANOVA, to identify strong associations between CVD and elde rly people, hypertension, higher weight, and abnormal cholesterol levels, while physical activity (a protective factor). A logistic regression model highlights age, blood pressure, and cholesterol as primary risk factors, with unexpected negative associati ons for smoking and alcohol, suggesting potential data issues. Model performance comparisons reveal CatBoost as the top performer with an accuracy of 0.734 and an ECE of 0.0064 and excels in probabilistic prediction (Brier score = 0.1824). Data challenges, including outliers and skewed distributions, indicate a need for improved preprocessing to enhance predictive reliability. Cardiovascular diseases (CVDs) encompass a range of conditions affecting the heart and blood vessels, including coronary heart disease, stroke, and heart failure.

Methods: We developed a self-supervised deep learning model that extracts meaningful patterns from multi-modal signals (Electroencephalography (EEG), Electrocardiography (ECG), and respiratory signals). The model was trained on data from 4,398 participants. Projection scores were derived by contrasting embeddings from individuals with and without CVD outcomes. External validation was conducted in an independent cohort with 1,093 participants. The source code is available on https://github.com/miraclehetech/sleep-ssl. Results: The projection scores revealed distinct and clinically meaningful patterns across modalities. ECG-derived features were predictive of both prevalent and incident cardiac conditions, particularly CVD mortality. EEG-derived features were predictive of incident hypertension and CVD mortality. Respiratory signals added complementary predictive value. Combining these projection scores with the Framingham Risk Score consistently improved predictive performance, achieving area under the curve values ranging from 0.607 to 0.965 across different outcomes. Findings were robustly replicated and validated in the external testing cohort. Conclusion: Our findings demonstrate that the proposed framework can generate individualized CVD risk scores directly from PSG data. The resulting projection scores have the potential to be integrated into clinical practice, enhancing risk assessment and supporting personalized care.